Both PharmAthene Inc. and Inclinix Inc. joined the CIC when it launched in 2003 and now will be leaving the nest for larger offices in the county.
PharmAthene, a biomedical research company that specializes in countering biological and chemical weapons, will be moving to its new location in the $250 million mixed use development at Park Place in Annapolis. The business, formed in 2001, has received $65 million in venture capital and private equity financing.
Inclinix,...
| This story has expired! You can purchase the full text in our news archives. |
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.
In order to post or vote on a comment, you must be signed in with a hometownannapolis account.
Take a look at a summary of Commenting Guidelines.
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.